Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Invisible Health Technologies was a U.S. health technology company launched in response to the COVID-19 pandemic. The company focused on commercializing and deploying pandemic-response products such as mass fever detection systems, HyperHEPA air filtration, and Far-UVC or 405 nm light-based environmental safety solutions for businesses, schools, and public venues. Public descriptions position IHT primarily as a distributor, integrator, and advisor rather than a therapeutics developer or drug discovery company. Its best-documented activity was serving as the U.S. authorized value-added reseller for Omnisense Systems' Sentry MK4 mass fever screening system. Available corporate records indicate the Florida entity later became inactive, suggesting the business is no longer operating as an active company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Invisible Health Technologies.